Literature DB >> 29424813

Survival Benefits From Metformin Use in Pancreatic Cancer: A Systemic Review and Meta-analysis.

Kamonkiat Wirunsawanya1, Veeravich Jaruvongvanich, Sikarin Upala.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29424813     DOI： 10.1097/MPA.0000000000001000

Source DB:  PubMed          Journal:  Pancreas        ISSN： 0885-3177            Impact factor:   3.327


× No keyword cloud information.
  4 in total

1.  Metformin Increases the Chemosensitivity of Pancreatic Cancer Cells to Gemcitabine by Reversing EMT Through Regulation DNA Methylation of miR-663.

Authors:  Yuqing Gu; Bin Zhang; Guangliang Gu; Xiaojun Yang; Zhuyin Qian
Journal:  Onco Targets Ther       Date:  2020-10-14       Impact factor: 4.147

2.  Metformin Use May Increase Risk of Pancreatic Cancer in Diabetic Women: An Analysis of the Korean National Health Insurance Service-National Health Screening Cohort Database.

Authors:  Joungyoun Kim; Yoon-Jong Bae; Hee-Taik Kang
Journal:  Korean J Fam Med       Date:  2022-09-20

3.  Mitochondrial Protein UQCRC1 is Oncogenic and a Potential Therapeutic Target for Pancreatic Cancer.

Authors:  Qing Wang; Mengge Li; Yu Gan; Shuheng Jiang; Jie Qiao; Wei Zhang; Yingchao Fan; Yuling Shen; Yanfang Song; Zihong Meng; Ming Yao; Jianren Gu; Zhigang Zhang; Hong Tu
Journal:  Theranostics       Date:  2020-01-12       Impact factor: 11.556

4.  The potential adjunctive benefit of adding metformin to standard treatment in inoperable cancer patients: a meta-analysis of randomized controlled trials.

Authors:  Zhonghua Wu; Bicheng Qu; Xuanzhang Huang; Yongxi Song; Peng Gao; Jinxin Shi; Cen Zhou; Zhenning Wang
Journal:  Ann Transl Med       Date:  2020-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.